View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Respiratory Infections News

SPONSORED CONTENT
September 19, 2024
3 min read
Save
Gum bleeding raises odds for asthma symptoms, COPD 10 years later

Gum bleeding raises odds for asthma symptoms, COPD 10 years later

Odds for asthma symptoms, COPD and chronic bronchitis went up if individuals reported earlier “often/always” vs. “never” gum bleeding, according to a poster presented at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 16, 2024
2 min read
Save

Artificial neural network has ‘high performance’ in detecting bronchopulmonary dysplasia

Artificial neural network has ‘high performance’ in detecting bronchopulmonary dysplasia

An artificial neural network demonstrated high accuracy in detecting bronchopulmonary dysplasia in infants using air flow data, according to a presentation at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 13, 2024
2 min read
Save

Histoplasmosis more common in rural areas of US

Histoplasmosis more common in rural areas of US

Cases of histoplasmosis are more common in rural areas of the United States and places with less health care infrastructure, according to a new study.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
September 11, 2024
1 min read
Save

COVID-19 booster coverage low among children on home ventilation

COVID-19 booster coverage low among children on home ventilation

Children with tracheostomy and home ventilation had low COVID-19 vaccination rates, especially for boosters, despite higher than average influenza vaccination coverage, according to a study published in JAMA Network Open.

SPONSORED CONTENT
September 06, 2024
2 min read
Save

Saline nasal drops shortened colds in young children, reduced household transmission

Saline nasal drops shortened colds in young children, reduced household transmission

Hypertonic saline nose drops shortened cold symptom duration in young children and decreased household transmission, according to findings presented at the European Respiratory Society International Congress in Vienna.

SPONSORED CONTENT
September 05, 2024
3 min read
Save

Q&A: RSV vaccination lowers risk for hospitalization in older patients

Q&A: RSV vaccination lowers risk for hospitalization in older patients

During their first season in use, respiratory syncytial virus vaccines reduced the risk for RSV-associated hospitalization by 75% among adults aged 60 years or older, according to a study.

SPONSORED CONTENT
August 23, 2024
2 min read
Save

US to offer free COVID-19 tests again beginning in September

US to offer free COVID-19 tests again beginning in September

The federal government will once again be distributing free at-home COVID-19 tests to households across the country starting next month, health officials announced Friday.

SPONSORED CONTENT
August 16, 2024
2 min read
Save

Study: Virally suppressed HIV does not increase mortality risk with pneumonia

Study: Virally suppressed HIV does not increase mortality risk with pneumonia

People with virally suppressed HIV who are hospitalized with community acquired pneumonia do not have a higher mortality risk than people without HIV, according to a study.

SPONSORED CONTENT
August 14, 2024
3 min read
Save

Inhaled molgramostim safe in nontuberculous mycobacterial infection

Inhaled molgramostim safe in nontuberculous mycobacterial infection

A quarter of adults with a refractory nontuberculous mycobacterial infection had culture conversion during a 48-week daily inhaled molgramostim treatment period, according to results published in Annals of the American Thoracic Society.

SPONSORED CONTENT
August 13, 2024
2 min read
Save

Pfizer: RSV vaccine generates strong response in immunocompromised adults

Pfizer: RSV vaccine generates strong response in immunocompromised adults

A dose of Pfizer’s respiratory syncytial virus vaccine was well tolerated and generated a strong immune response among adults aged 59 years or younger, the company announced in a press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails